Trisha Ramraj has a Masters Degree in Public Health. Her research interests include maternal and child health and HIV prevention in adolescents and young women. She is the project manager on the COVID KIDS study which aims to provide a detailed picture of the effects of COVID-19 on the overall health of children. She is also the project manager on the PedMAb study, a Phase I clinical trial study to determine safety and pharmacokinetics of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs) in HIV-1 exposed uninfected neonates and infants. She is a co-investigator on the SHeS'Cap – PrEP study which aims to identify effective and feasible PrEP models of care for improving PrEP uptake, continuation and adherence among AGYW and ABYM.